However, strong evidence suggests that EZH2 acquires a distinct, tumour‐promoting role in malignant neural cells, as inhibition of its function impairs the maintenance of various CNS cancers 21, 22, 23. The gene discussed is EZH2; the disease is central nervous system cancer.